Kaplan Robert M, Ries Andrew L
Department of Health Services, University of California, Los Angeles, Los Angeles, CA 90095-1772, USA.
Proc Am Thorac Soc. 2008 May 1;5(4):561-6. doi: 10.1513/pats.200706-080ET.
Patients with emphysema may experience reduced health-related quality of life (HRQOL). HRQOL measures have evolved from two different measurement traditions: psychometric theory and decision theory. Psychometric methods typically create a profile of outcomes, whereas decision theory methods offer a summary score on a continuum ranging from 0.0 (for death or worst possible health) to 1.0 (for best possible health). Decision theory methods are better suited for cost-effectiveness studies. Generic HRQOL measures can be applied to any disease population, whereas disease-targeted measures are tailored to a specific clinical condition. Disease-targeted measures are typically more sensitive to clinical change, but cannot offer a comparison basis for different clinical conditions. This article reviews the measurement of HRQOL in patients with emphysema. The National Emphysema Treatment Trial (NETT) offers an example of the application of both generic and disease-targeted, as well as profile and decision theory, methods. The NETT illustrates how HRQOL measures can be used to assess outcomes and estimate cost-effectiveness in a major clinical trial.
肺气肿患者的健康相关生活质量(HRQOL)可能会下降。HRQOL测量方法源自两种不同的测量传统:心理测量理论和决策理论。心理测量方法通常会生成一份结果概况,而决策理论方法则在从0.0(代表死亡或最差健康状况)到1.0(代表最佳健康状况)的连续区间上给出一个汇总分数。决策理论方法更适合成本效益研究。通用的HRQOL测量方法可应用于任何疾病人群,而针对特定疾病的测量方法则是针对特定临床状况量身定制的。针对特定疾病的测量方法通常对临床变化更敏感,但无法为不同临床状况提供比较基础。本文回顾了肺气肿患者HRQOL的测量方法。国家肺气肿治疗试验(NETT)提供了一个同时应用通用和针对特定疾病的测量方法,以及概况和决策理论方法的例子。NETT说明了HRQOL测量方法如何在一项大型临床试验中用于评估结果和估计成本效益。